Skip to content
value.today

Medical 21, Inc.

🇺🇸 Minneapolis, Minnesota, USABiotechnologyFounded 2016
Total raised
$16 M
3 rounds on record
Latest round
$10 M
Feb 2023
First round on record
Feb 2019
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Medical 21, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2023$10 MNo. 3$10 to $50 million

Medical 21, Inc.: Raise no. 3, Feb 2023

Investors in this round

39 investors had bought by the notice of Aug 21, 2025: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $20 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Minnesota

People named in the notice

  • Andrea Sweeney · Executive Officer
  • Chaid Schwarz · Executive Officer
  • Eric Solien · Executive Officer
  • Erik Hermansen · Executive Officer
  • Jeff Vreeman · Executive Officer
  • Manny Villafana · Executive Officer, Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “A portion of the offering proceeds will be used for general working capital purposes, including the payment of salaries to officers.”

Signed by Manny Villafana, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Aug 21, 2025. Read the notice at the SEC.

equitySEC
Sep 2022$3 MNo. 2$2 to $10 million

Medical 21, Inc.: Raise no. 2, Sep 2022

Investors in this round

1 investor had bought by the notice of Sep 20, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $20 M offered; $18 M still to sell
Smallest investment taken
$2,500,000
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Minnesota

People named in the notice

  • Manny Villafana · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “A portion of the offering proceeds will be used for general working capital purposes, including the payment of salaries to officers.”

Signed by Manny Villafana, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 20, 2022. Read the notice at the SEC.

equitySEC
Feb 2019$3 MNo. 1$2 to $10 million

Medical 21, Inc.: Raise no. 1, Feb 2019

Investors in this round

15 investors had bought by the notice of Jan 12, 2021: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $10 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Minnesota

People named in the notice

  • Manny Villafana · Executive Officer, Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “A portion of the offering proceeds will be used for general working capital purposes, including the payment of salaries to officers.”

Signed by Manny Villafana, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 12, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medical 21, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2025).

    SEC Form D · Aug 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2025

That is all the official record says: Medical 21, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Medical 21, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 39 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medical 21, Inc.
NameRoleNamed in
Andrea SweeneyExecutive officerAug 2025
Chaid SchwarzExecutive officerAug 2025
Eric SolienExecutive officerAug 2025
Erik HermansenExecutive officerAug 2025
Jeff VreemanExecutive officerAug 2025
Manny VillafanaExecutive officerAug 2025
Manny VillafanaDirectorAug 2025
Manny VillafanaPromoterAug 2025
Eric SolienPromoterJan 2020